Great West Life Assurance CO Chemo Centryx, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 01, 2022	BUY	$22.17 - $51.8 $183,390 - $428,489	8,272 New	8,272 $427,000
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $11,781 - $25,960	-641 Reduced 19.68%	2,616 $95,000
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $20,802 - $28,728	420 Added 14.8%	3,257 $166,000
Q3 2020 Nov 17, 2020	BUY	$46.35 - $61.69 $131,494 - $175,014	2,837 New	2,837 $155,000
Q3 2020 Nov 13, 2020	SELL	$46.35 - $61.69 $131,494 - $175,014	-2,837 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$6.81 - $39.55 $19,319 - $112,203	2,837 New	2,837 $112,000
Q3 2019 Oct 25, 2019	SELL	$6.47 - $8.96 $35,759 - $49,521	-5,527 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$8.31 - $14.85 $45,929 - $82,075	5,527 New	5,527 $0

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.